Generic Pharmaceutical Manufacturer
H.R. 2725- FDA Safety Over Sequestration Act; S. 1413 FDA User Fee Protection Act. P.L. 111-148: Patient Protection and Affordable Healthcare Act Provisions relating to biosimilar drug products; H.R. 1919 & H.R. 3204 Safeguarding America's Pharmaceuticals Act of 2013; S. 957 The Drug Supply Chain Security Act. S. 959 The Phamaceutical Quality, Security & Accountability Act; H.R. 3204 The Compounding Clarity Act; Issues related to FDA rule on drug labeling.
BUD - Budget/Appropriations HCR - Health Issues PHA - Pharmacy
135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BROWN RUDNICK LLP
601 13th Street, NW, 6th Floor, Washington, DC, 20005, US
CHRISTOPHER BOWLIN (Dep Asst Secr for Congr & Intgv Affairs) LISA LAYMAN (SPA, Sen Stabenow(05-07)) HENRY W MENN (Min SD & Counsel, Cmte on Vet Affairs (04)) CHRISTOPHER BOWLIN HENRY W MENN LISA LAYMAN CHRISTOPHER BOWLIN HENRY W MENN LISA LAYMAN
Dep Asst Secr for Congr & Intgv Affairs SPA, Sen Stabenow(05-07) Min SD & Counsel, Cmte on Vet Affairs (04)